Schizophrenia (SZ) is a pervasive neurodevelopmental disorder that entails social and cognitive deficits, including marked language problems. Its complex multifactorial etiopathogenesis, including genetic and environmental factors, is still widely uncertain. SZ incidence has always been high and quite stable in human populations, across time and regardless of cultural implications, for unclear reasons. It has been hypothesized that SZ pathophysiology may involve the biological components that changed during the recent human evolutionary history, and led to our distinctive mode of cognition, which includes language skills. In this paper we explore this hypothesis, focusing on the self-domestication of the human species. This has been claimed to account for many human-specific distinctive traits, including aspects of our behavior and cognition, and to favor the emergence of complex languages through cultural evolution. The “domestication syndrome” in mammals comprises the constellation of traits exhibited by domesticated strains, seemingly resulting from the hypofunction of the neural crest. It is our intention to show that people with SZ exhibit more marked domesticated traits at the morphological, physiological, and behavioral levels. We also show that genes involved in domestication and neural crest development and function comprise nearly 20% of SZ candidates, most of which exhibit altered expression profiles in the brain of SZ patients, specifically in areas involved in language processing. Based on these observations, we conclude that SZ may represent an abnormal ontogenetic itinerary for the human faculty of language, resulting, at least in part, from changes in genes important for the domestication syndrome and primarily involving the neural crest.

1.
Aberg KA, McClay JL, Nerella S, Clark S, Kumar G, Chen W, Khachane AN, Xie L, Hudson A, Gao G, Harada A, Hultman CM, Sullivan PF, Magnusson PK, van den Oord EJ (2014): Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry 71:255-264.
2.
Adam MP, Schelley S, Gallagher R, Brady AN, Barr K, Blumberg B, Shieh JT, Graham J, Slavotinek A, Martin M, Keppler-Noreuil K, Storm AL, Hudgins L (2006): Clinical features and management issues in Mowat-Wilson syndrome. Am J Med Genet A 140:2730-2741.
3.
Akabaliev VH, Sivkov ST, Mantarkov MJ, Ahmed-Popova FM (2011): Biomarker profile of minor physical anomalies in schizophrenia patients. Folia Med (Plovdiv) 53:45-51.
4.
Aksoy-Poyraz C, Poyraz BÇ, Turan Ş, Arikan MK (2011): Minor physical anomalies and neurological soft signs in patients with schizophrenia and their siblings. Psychiatry Res 190:85-90.
5.
Alappat S, Zhang ZY, Chen YP (2003): Msx homeobox gene family and craniofacial development. Cell Res 13:429-442.
6.
Albert FW, Somel M, Carneiro M, Aximu-Petri A, Halbwax M, Thalmann O, Blanco-Aguiar JA, Plyusnina IZ, Trut L, Villafuerte R, Ferrand N, Kaiser S, Jensen P, Pääbo S (2012): A comparison of brain gene expression levels in domesticated and wild animals. PLoS Genet 8:e1002962.
7.
Allen T, Willard VW, Anderson LM, Hardy KK, Bonner MJ (2016): Social functioning and facial expression recognition in children with neurofibromatosis type 1. J Intellect Disabil Res 60:282-293.
8.
Amato R, Pinelli M, Monticelli A, Miele G, Cocozza S (2010): Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation. BMC Evol Biol 10:351.
9.
Anderson JL, Gutmann DH (2015): Neurofibromatosis type 1. Handb Clin Neurol 132:75-86.
10.
Attanasio C, Nord AS, Zhu Y, Blow MJ, Li Z, Liberton DK, Morrison H, Plajzer-Frick I, Holt A, Hosseini R, Phouanenavong S, Akiyama JA, Shoukry M, Afzal V, Rubin EM, FitzPatrick DR, Ren B, Hallgrímsson B, Pennacchio LA, Visel A (2013): Fine tuning of craniofacial morphology by distant-acting enhancers. Science 342:1241006.
11.
Au PY, Racher HE, Graham JM Jr, Kramer N, Lowry RB, Parboosingh JS, Innes AM; FORGE Canada Consortium (2014): De novo exon 1 missense mutations of SKI and Shprintzen-Goldberg syndrome: two new cases and a clinical review. Am J Med Genet A 164A:676-684.
12.
Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, Salomon D, Schork NJ, Fanous AH, O'Donovan MC, Niculescu AB (2012): Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 17:887-905.
13.
Baranek C, Atanasoski S (2012): Modulating epigenetic mechanisms: the diverse functions of Ski during cortical development. Epigenetics 7:676-679.
14.
Baribeau DA, Anagnostou E (2013): A comparison of neuroimaging findings in childhood onset schizophrenia and autism spectrum disorder: a review of the literature. Front Psychiatry 4:175.
15.
Barnes MR, Huxley-Jones J, Maycox PR, Lennon M, Thornber A, Kelly F, Bates S, Taylor A, Reid J, Jones N, Schroeder J, Scorer CA, Davies C, Hagan JJ, Kew JN, Angelinetta C, Akbar T, Hirsch S, Mortimer AM, Barnes TR, de Belleroche J (2011): Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J Neurosci Res 89:1218-1227.
16.
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al (2013): NCBI GEO: archive for functional genomics data sets - update. Nucleic Acids Res 41:D991-D995.
17.
Beckmann H, Lang RE, Gattaz WF (1985): Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology 10:187-191.
18.
Bedi U, Mishra VK, Wasilewski D, Scheel C, Johnsen SA (2014): Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer. Oncotarget 5:2016-2029.
19.
Benítez-Burraco A (2016): A biolinguistic approach to sign languages; in Marschark M, Spencer PE (eds): The Oxford Handbook of Deaf Studies: Language and Language Development. Oxford, Oxford University Press, pp 247-263.
20.
Benítez-Burraco A, Boeckx C (2015): Possible functional links among brain- and skull-related genes selected in modern humans. Front Psychol 6:794.
21.
Benítez-Burraco A, Lattanzi W, Murphy E (2016): Language impairments in ASD resulting from a failed domestication of the human brain. Front Neurosci 10:373.
22.
Benítez-Burraco A, Murphy E (2016): The oscillopathic nature of language deficits in autism: from genes to language evolution. Front Hum Neurosci 10:120.
23.
Berger SM, Bartsch D (2014): The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. Cell Tissue Res 357:463-476.
24.
Bertelsen B, Melchior L, Jensen LR, Groth C, Glenthøj B, Rizzo R, Debes NM, Skov L, Brøndum-Nielsen K, Paschou P, Silahtaroglu A, Tümer Z (2014): Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome. Eur J Hum Genet 22:1283-1289.
25.
Bigdeli TB, Ripke S, Bacanu SA, Lee SH, Wray NR, Gejman PV, Rietschel M, Cichon S, St Clair D, Corvin A, Kirov G, McQuillin A, Gurling H, Rujescu D, Andreassen OA, Werge T, Blackwood DH, Pato CN, Pato MT, Malhotra AK, O'Donovan MC, Kendler KS, Fanous AH; Schizophrenia Working Group of the Psychiatric Genomics Consortium (2016): Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness. Am J Med Genet B Neuropsychiatr Genet 171B:276-289.
26.
Boeckx C, Benítez-Burraco A (2014a): The shape of the human language-ready brain. Front Psychol 5:282.
27.
Boeckx C, Benítez-Burraco A (2014b): Globularity and language-readiness: generating new predictions by expanding the set of genes of interest. Front Psychol 5:1324.
28.
Boyd PJ, Cunliffe VT, Roy S, Wood JD (2015): Sonic hedgehog functions upstream of disrupted-in-schizophrenia 1 (disc1): implications for mental illness. Biol Open 4:1336-1343.
29.
Boyle MI, Jespersgaard C, Brøndum-Nielsen K, Bisgaard AM, Tümer Z (2015): Cornelia de Lange syndrome. Clin Genet 88:1-12.
30.
Bozdagi O, Wang XB, Nikitczuk JS, Anderson TR, Bloss EB, Radice GL, Zhou Q, Benson DL, Huntley GW (2010): Persistence of coordinated long-term potentiation and dendritic spine enlargement at mature hippocampal CA1 synapses requires N-cadherin. J Neurosci 30:9984-9989.
31.
Bradley AJ, Dinan TG (2010): A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol 24:91-118.
32.
Brei NG, Klein-Tasman BP, Schwarz GN, Casnar CL (2014): Language in young children with neurofibromatosis-1: relations to functional communication, attention, and social functioning. Res Dev Disabil 35:2495-2504.
33.
Brown AS (2011): The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23-58.
34.
Brüne M (2004): Schizophrenia - an evolutionary enigma? Neurosci Biobehav Rev 28:41-53.
35.
Bury LA, Sabo SL (2014): Dynamic mechanisms of neuroligin-dependent presynaptic terminal assembly in living cortical neurons. Neural Dev 9:13.
36.
Cannon M, Jones PB, Murray RM (2002): Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159:1080-1092.
37.
Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R; North American Prodrome Longitudinal Study Consortium (2015): Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry 77:147-157.
38.
Caronia G, Wilcoxon J, Feldman P, Grove EA (2010): Bone morphogenetic protein signaling in the developing telencephalon controls formation of the hippocampal dentate gyrus and modifies fear-related behavior. J Neurosci 30:6291-6301.
39.
Castellano S, Parra G, Sánchez-Quinto FA, Racimo F, Kuhlwilm M, Kircher M, Sawyer S, Fu Q, Heinze A, Nickel B, Dabney J, Siebauer M, White L, Burbano HA, Renaud G, Stenzel U, Lalueza-Fox C, de la Rasilla M, Rosas A, Rudan P, Brajković D, Kucan Ž, Gušic I, Shunkov MV, Derevianko AP, Viola B, Meyer M, Kelso J, Andrés AM, Pääbo S (2014): Patterns of coding variation in the complete exomes of three Neandertals. Proc Natl Acad Sci USA 111:6666-6671.
40.
Chang L, Kessler DS (2010): Foxd3 is an essential Nodal-dependent regulator of zebrafish dorsal mesoderm development. Dev Biol 342:39-50.
41.
Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA; Members of the Bipolar Disorder Genome Study (BiGS) Consortium, Gershon ES, Liu C (2013): Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry 18:1308-1314.
42.
Cheung M, Briscoe J (2003): Neural crest development is regulated by the transcription factor Sox9. Development 130:5681-5693.
43.
Cho KK, Hoch R, Lee A, T, Patel T, Rubenstein JL, Sohal VS (2015): Gamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5/6(+/-) mice. Neuron 85:1332-1343.
44.
Christophersen NS, Grønborg M, Petersen TN, Fjord-Larsen L, Jørgensen JR, Juliusson B, Blom N, Rosenblad C, Brundin P (2007): Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation. Exp Neurol 204:791-801.
45.
Ciufolini S, Dazzan P, Kempton MJ, Pariante C, Mondelli V (2014): HPA axis response to social stress is attenuated in schizophrenia but normal in depression: evidence from a meta-analysis of existing studies. Neurosci Biobehav Rev 47:359-368.
46.
Clarke DJ, Buckley ME (1989): Familial association of albinism and schizophrenia. Br J Psychiatry 155:551-553.
47.
Cohen MM Jr (2000): Craniofacial disorders caused by mutations in homeobox genes MSX1 and MSX2. J Craniofac Genet Dev Biol 20:19-25.
48.
Compton MT, Bollini AM, McKenzie Mack L, Kryda AD, Rutland J, Weiss PS, Bercu Z, Esterberg ML, Walker EF (2007): Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophr Res 94:64-73.
49.
Coulpier M, Anders J, Ibáñez CF (2002): Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival. J Biol Chem 277:1991-1999.
50.
Crespi B, Badcock C (2008): Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci 31:241-320.
51.
Crow TJ (2000): Schizophrenia as the price that Homo sapiens pays for language: a resolution of the central paradox in the origin of the species. Brain Res Brain Res Rev 31:118-129.
52.
Darrell-Berry H, Berry K, Bucci S (2016): The relationship between paranoia and aggression in psychosis: a systematic review. Schizophr Res 172:169-176.
53.
Darwin C (1871): The Descent of Man, and Selection in Relation to Sex. London, Murray.
54.
Datta D, Arion D, Corradi JP, Lewis DA (2015): Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia. Biol Psychiatry 78:775-785.
55.
Davis MC, Green MF, Lee J, Horan WP, Senturk D, Clarke AD, Marder SR (2014): Oxytocin-augmented social cognitive skills training in schizophrenia. Neuropsychopharmacology 39:2070-2077.
56.
Deacon TW (2009): Relaxed selection and the role of epigenesis in the evolution of language; in Blumberg M, Freeman J, Robinson J (eds): Oxford Handbook of Developmental Behavioral Neuroscience. New York, Oxford University Press, pp 730-752.
57.
de Baumont A, Maschietto M, Lima L, Carraro DM, Olivieri EH, Fiorini A, Barreta LA, Palha JA, Belmonte-de-Abreu P, Moreira Filho CA, Brentani H (2015): Innate immune response is differentially dysregulated between bipolar disease and schizophrenia. Schizophr Res 161:215-221.
58.
De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A (2012): Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des 18:486-494.
59.
Deutsch CK, Levy DL, Price SF, Bodkin JA, Boling L, Coleman MJ, Johnson F, Lerbinger J, Matthysse S, Holzman PS (2015): Quantitative measures of craniofacial dysmorphology in a family study of schizophrenia and bipolar illness. Schizophr Bull 41:1309-1316.
60.
Drerup CM, Wiora HM, Topczewski J, Morris JA (2009): Disc1 regulates foxd3 and sox10 expression, affecting neural crest migration and differentiation. Development 136:2623-2632.
61.
Escot S, Blavet C, Faure E, Zaffran S, Duband JL, Fournier-Thibault C (2016): Disruption of CXCR4 signaling in pharyngeal neural crest cells causes DiGeorge syndrome-like malformations. Development 143:582-588.
62.
Feifel D, Macdonald K, Cobb P, Minassian A (2012): Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia. Schizophr Res 139:207-210.
63.
Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A (2010): Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 68:678-680.
64.
Ferrarelli F, Sarasso S, Guller Y, Riedner BA, Peterson MJ, Bellesi M, Massimini M, Postle BR, Tononi G (2012): Reduced natural oscillatory frequency of frontal thalamocortical circuits in schizophrenia. Arch Gen Psychiatry 69:766-774.
65.
Filatova S, Koivumaa-Honkanen H, Hirvonen N, Freeman A, Ivandic I, Hurtig T, Khandaker GM, Jones PB, Moilanen K, Miettunen J (2017): Early motor developmental milestones and schizophrenia: a systematic review and meta-analysis. Schizophr Res doi: 10.1016/j.schres.2017.01.029.
66.
Filová B, Ostatníková D, Celec P, Hodosy J (2013): The effect of testosterone on the formation of brain structures. Cells Tissues Organs 197:169-177.
67.
Fisher SE, Francks C, Marlow AJ, MacPhie IL, Newbury DF, Newbury DF, Cardon LR, Ishikawa-Brush Y, Richardson AJ, Talcott JB, Gayán J, Olson RK, Pennington BF, Smith SD, DeFries JC, Stein JF, Monaco AP (2002): Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia. Nat Genet 30:86-91.
68.
Frank SM (1978): Psycholinguistic findings in Gilles de la Tourette syndrome. J Commun Disord 11:349-363.
69.
Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson JS, Roussos P, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, McCarroll SA, Holmans P, Sklar P, Owen MJ, Purcell SM, O'Donovan MC (2014): De novo mutations in schizophrenia implicate synaptic networks. Nature 506:179-184.
70.
Garavelli L, Ivanovski I, Caraffi SG, Santodirocco D, Pollazzon M, Cordelli DM, Abdalla E, Accorsi P, Adam MP, Baldo C, Bayat A, Belligni E, Bonvicini F, Breckpot J, Callewaert B, Cocchi G, Cuturilo G, Devriendt K, Dinulos MB, Djuric O, Epifanio R, Faravelli F, Formisano D, Giordano L, Grasso M, Grønborg S, Iodice A, Iughetti L, Lacombe D, Maggi M, Malbora B, Mammi I, Moutton S, Møller R, Muschke P, Napoli M, Pantaleoni C, Pascarella R, Pellicciari A, Poch-Olive ML, Raviglione F, Rivieri F, Russo C, Savasta S, Scarano G, Selicorni A, Silengo M, Sorge G, Tarani L, Tone LG, Toutain A, Trimouille A, Valera ET, Vergano SS, Zanotta N, Zollino M, Dobyns WB, Paciorkowski AR (2016): Neuroimaging findings in Mowat-Wilson syndrome: a study of 54 patients. Genet Med DOI: 10.1038/gim. 2016.176.
71.
Garg S, Plasschaert E, Descheemaeker MJ, Huson S, Borghgraef M, Vogels A, Evans DG, Legius E, Green J (2015): Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord 45:1649-1657.
72.
Geoffroy PA, Etain B, Houenou J (2013): Gene × environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging. Front Psychiatry 4:136.
73.
Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J, Williams H, Nikolov I, Williams N, Ivanov D, Davis KL, Haroutunian V, Buxbaum JD, Craddock N, Kirov G, Owen MJ, O'Donovan MC (2006): Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci USA 103:12469-12474.
74.
Gibson CM, Penn DL, Smedley KL, Leserman J, Elliott T, Pedersen CA (2014): A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia. Schizophr Res 156:261-265.
75.
Gil-Sanz C, Landeira B, Ramos C, Costa MR, Müller U (2014): Proliferative defects and formation of a double cortex in mice lacking Mltt4 and Cdh2 in the dorsal telencephalon. J Neurosci 34:10475-10487.
76.
Gimelli S, Capra V, Di Rocco M, Leoni M, Mirabelli-Badenier M, Schiaffino MC, Fiorio P, Cuoco C, Gimelli G, Tassano E (2014): Interstitial 7q31.1 copy number variations disrupting IMMP2L gene are associated with a wide spectrum of neurodevelopmental disorders. Mol Cytogenet 7:54.
77.
Girshkin L, O'Reilly N, Quidé Y, Teroganova N, Rowland JE, Schofield PR, Green MJ (2016): Diurnal cortisol variation and cortisol response to an MRI stressor in schizophrenia and bipolar disorder. Psychoneuroendocrinology 67:61-69.
78.
Gitton Y, Benouaiche L, Vincent C, Heude E, Soulika M, Bouhali K, Couly G, Levi G (2011): Dlx5 and Dlx6 expression in the anterior neural fold is essential for patterning the dorsal nasal capsule. Development 138:897-903.
79.
Glaser B, Mumme DL, Blasey C, Morris MA, Dahoun SP, Antonarakis SE, Reiss AL, Eliez S (2002): Language skills in children with velocardiofacial syndrome (deletion 22q11.2). J Pediatr 140:753-758.
80.
Gleeson PC, Worsley R, Gavrilidis E, Nathoo S, Ng E, Lee S, Kulkarni J (2016): Menstrual cycle characteristics in women with persistent schizophrenia. Aust NZ J Psychiatry 50:481-487.
81.
Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C, Bradfield JP, Zhang H, Sleiman PM, Flory JH, Imielinski M, Frackelton EC, Chiavacci R, Thomas KA, Garris M, Otieno FG, Davidson M, Weiser M, Reichenberg A, Davis KL, Friedman JI, Cappola TP, Margulies KB, Rader DJ, Grant SF, Buxbaum JD, Gur RE, Hakonarson H (2010): Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci USA 107:10584-10589.
82.
Glovinsky D, Kalogeras KT, Kirch DG, Suddath R, Wyatt RJ (1994): Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication. Schizophr Res 11:273-276.
83.
Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, Straub V, Robb S, Quinlivan R, Feng L, Jimenez-Mallebrera C, Mercuri E, Manzur AY, Kinali M, Torelli S, Brown SC, Sewry CA, Bushby K, Topaloglu H, North K, Abbs S, Muntoni F (2007): Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 130:2725-2735.
84.
Gogos A, Sbisa AM, Sun J, Gibbons A, Udawela M, Dean B (2015): A role for estrogen in schizophrenia: clinical and preclinical findings. Int J Endocrinol 2015:615356.
85.
Gokhman D, Lavi E, Prüfer K, Fraga MF, Riancho JA, Kelso J, Pääbo S, Meshorer E, Carmel L (2014): Reconstructing the DNA methylation maps of the Neandertal and the Denisovan. Science 344:523-527.
86.
Goldberg TE, Weinberger DR (2004): Genes and the parsing of cognitive processes. Trends Cogn Sci 8:325-335.
87.
González-Giraldo Y, Rojas J, Novoa P, Mueller ST, Piper BJ, Adan A, Forero DA (2014): Functional polymorphisms in BDNF and COMT genes are associated with objective differences in arithmetical functioning in a sample of young adults. Neuropsychobiology 70:152-157.
88.
Gourion D, Goldberger C, Bourdel MC, Jean Bayle F, Lôo H, Krebs MO (2004): Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res 125:21-28.
89.
Gunnar MR, Wewerka S, Frenn K, Long JD, Griggs C (2009): Developmental changes in hypothalamus-pituitary-adrenal activity over the transition to adolescence: normative changes and associations with puberty. Dev Psychopathol 21:69-85.
90.
Gunnell D, Rasmussen F, Fouskakis D, Tynelius P, Harrison G (2003): Patterns of fetal and childhood growth and the development of psychosis in young males: a cohort study. Am J Epidemiol 158:291-300.
91.
Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A (2001): Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27:293-298.
92.
Haberlova J, Mitrović Z, Zarković K, Lovrić D, Barić V, Berlengi L, Bilić K, Fumić K, Kranz K, Huebner A, von der Hagen M, Barresi R, Bushby K, Straub V, Barić I, Lochmüller H (2014): Psycho-organic symptoms as early manifestation of adult onset POMT1-related limb girdle muscular dystrophy. Neuromuscul Disord 24:990-992.
93.
Haddad-Tóvolli R, Heide M, Zhou X, Blaess S, Álvarez-Bolado G (2012): Mouse thalamic differentiation: gli-dependent pattern and gli-independent prepattern. Front Neurosci 6:27.
94.
Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS (2013): Brain volumes in schizophrenia: a meta-analysis in over 18,000 subjects. Schizophr Bull 39:1129-1138.
95.
Hajnal A, Csábi G, Herold R, Jeges S, Halmai T, Trixler D, Simon M, Tóth ÁL, Tényi T (2016): Minor physical anomalies are more common among the first-degree unaffected relatives of schizophrenia patients - results with the Méhes Scale. Psychiatry Res 237:224-228.
96.
Han J, Ishii M, Bringas P Jr, Maas RL, Maxson RE Jr, Chai Y (2007): Concerted action of Msx1 and Msx2 in regulating cranial neural crest cell differentiation during frontal bone development. Mech Dev 124:729-745.
97.
Hannula-Jouppi K, Kaminen-Ahola N, Taipale M, Eklund R, Nopola-Hemmi J, Kääriäinen H, Kere J (2005): The axon guidance receptor gene ROBO1 is a candidate gene for developmental dyslexia. PLoS Genet 1:e50.
98.
Hare B, Tomasello M (2005): Human-like social skills in dogs? Trends Cogn Sci 9:439-444.
99.
Hata K, Iida J, Iwasaka H, Negoro HI, Ueda F, Kishimoto T (2003): Minor physical anomalies in childhood and adolescent onset schizophrenia. Psychiatry Clin Neurosci 57:17-21.
100.
Hattori T, Shimizu S, Koyama Y, Emoto H, Matsumoto Y, Kumamoto N, Yamada K, Takamura H, Matsuzaki S, Katayama T, Tohyama M, Ito A (2014): DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One 9:e88506.
101.
Haukka J, Suvisaari J, Häkkinen L, Lönnqvist J (2008): Growth pattern and risk of schizophrenia. Psychol Med 38:63-70.
102.
Haukvik UK, Hartberg CB, Agartz I (2013): Schizophrenia - what does structural MRI show? Tidsskr Nor Laegeforen 133:850-853.
103.
Havelka D, Prikrylova-Kucerova H, Prikryl R, Ceskova E (2016): Cognitive impairment and cortisol levels in first-episode schizophrenia patients. Stress 19:383-389.
104.
Hecht EE, Gutman DA, Preuss TM, Sánchez MM, Parr LA, Rilling JK (2013): Process versus product in social learning: comparative diffusion tensor imaging of neural systems for action execution-observation matching in macaques, chimpanzees, and humans. Cortex 23:1014-1024.
105.
Hegarty SV, Sullivan AM, O'Keeffe GW (2015): Zeb2: a multifunctional regulator of nervous system development. Prog Neurobiol 132:81-95.
106.
Hempel RJ, Tulen JH, van Beveren NJ, Röder CH, de Jong FH, Hengeveld MW (2010): Diurnal cortisol patterns of young male patients with schizophrenia. Psychiatry Clin Neurosci 64:548-554.
107.
Hetz S, Acikgoez A, Voss U, Nieber K, Holland H, Hegewald C, Till H, Metzger R, Metzger M (2014): In vivo transplantation of neurosphere-like bodies derived from the human postnatal and adult enteric nervous system: a pilot study. PLoS One 9:e93605.
108.
Hinzen W, Rosselló J (2015): The linguistics of schizophrenia: thought disturbance as language pathology across positive symptoms. Front Psychol 6:971.
109.
Hirayasu Y, Shenton ME, Salisbury DF, Dickey CC, Fischer IA, Mazzoni P, Kisler T, Arakaki H, Kwon JS, Anderson JE, Yurgelun-Todd D, Tohen M, McCarley RW (1998): Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first episode affective disorder and normal subjects. Am J Psychiatry 155:1384-1391.
110.
Ho BC, Epping E, Wang K, Andreasen NC, Librant A, Wassink TH (2008): Basic helix-loop-helix transcription factor NEUROG1 and schizophrenia: effects on illness susceptibility, MRI brain morphometry and cognitive abilities. Schizophr Res 106:192-199.
111.
Hochman KM, Lewine RR (2004): Age of menarche and schizophrenia onset in women. Schizophr Res 69:183-188.
112.
Iannuzzi S, Albaret JM, Chignac C, Faure-Marie N, Barry I, Karsenty C, Chaix Y (2016): Motor impairment in children with neurofibromatosis type 1: effect of the comorbidity with language disorders. Brain Dev 38:181-187.
113.
Ismail B, Cantor-Graae E, McNeil TF (1998): Minor physical anomalies in schizophrenic patients and their siblings. Am J Psychiatry 155:1695-1702.
114.
Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T, Kato T (2005): DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25:5376-5381.
115.
Iwashiro N, Koike S, Satomura Y, Suga M, Nagai T, Natsubori T, Tada M, Gonoi W, Takizawa R, Kunimatsu A, Yamasue H, Kasai K (2016): Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: a multi-modal neuroimaging study. Schizophr Res 172:9-15.
116.
Jasińska KK, Molfese PJ, Kornilov SA, Mencl WE, Frost SJ, Lee M, Pugh KR, Grigorenko EL, Landi N (2016): The BDNF Val66Met polymorphism influences reading ability and patterns of neural activation in children. PLoS One 11:e0157449.
117.
Jing J, Ren Y, Zong Z, Liu C, Kamiya N, Mishina Y, Liu Y, Zhou X, Feng JQ (2013): BMP receptor 1A determines the cell fate of the postnatal growth plate. Int J Biol Sci 9:895-906.
118.
Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM (1996): GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113-1124.
119.
Jones EG, Rubenstein JLR (2004): Expression of regulatory genes during differentiation of thalamic nuclei in mouse and monkey. J Comp Neurol 477:55-80.
120.
Kabir ZD, Lee AS, Rajadhyaksha AM (2016): L-type Ca2+ channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes. J Physiol 594:5823-5837.
121.
Kadowaki M, Nakamura S, Machon O, Krauss S, Radice GL, Takeichi M (2007): N-cadherin mediates cortical organization in the mouse brain. Dev Biol 304:22-33.
122.
Kagawa, H, Yamada, H, Lin R-S, Mizuta, T, Hasegawa T, Okanoya K (2012): Ecological correlates of song complexity in white-rumped munias: the implication of relaxation of selection as a cause for signal variation in birdsong. Interact Stud 13:263-284.
123.
Kebir O, Mouaffak F, Chayet M, Leroy S, Tordjman S, Amado I, Krebs MO (2009): Semantic but not phonological verbal fluency associated with BDNF Val66Met polymorphism in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 150B:441-442.
124.
Keller A, Castellanos FX, Vaituzis AC, Jeffries NO, Giedd JN, Rapoport JL (2003): Progressive loss of cerebellar volume in childhood-onset schizophrenia. Am J Psychiatry 160:128-133.
125.
Khadka D, Luo T, Sargent TD (2006): Msx1 and Msx2 have shared essential functions in neural crest but may be dispensable in epidermis and axis formation in Xenopus. Int J Dev Biol 50:499-502.
126.
Kielar C, Wishart TM, Palmer A, Dihanich S, Wong AM, Macauley SL, Chan CH, Sands MS, Pearce DA, Cooper JD, Gillingwater TH (2009): Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease. Hum Mol Genet 18:4066-4080.
127.
Kircher TT, Oh TM, Brammer MJ, McGuire PK (2005): Neural correlates of syntax production in schizophrenia. Br J Psychiatry 186:209-214.
128.
Kraus P, Lufkin T (2006): Dlx homeobox gene control of mammalian limb and craniofacial development. Am J Med Genet A 140:1366-1374.
129.
Krishnan S, Watkins KE, Bishop DV (2016): Neurobiological basis of language learning difficulties. Trends Cogn Sci 20:701-714.
130.
Lamminranta S, Aberg LE, Autti T, Moren R, Laine T, Kaukoranta J, Santavuori P (2001): Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis. J Intellect Disabil Res 45:8-17.
131.
Lanz TA, Guilmette E, Gosink MM, Fischer JE, Fitzgerald LW, Stephenson DT, Pletcher MT (2013): Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action. Mol Autism 4:45.
132.
Lapierre D, Braun CM, Hodgins S, Toupin J, Léveillée S, Constantineau C (1995): Neuropsychological correlates of violence in schizophrenia. Schizophr Bull 21:253-262.
133.
Lattanzi W (2016): Molecular Genetics of Craniosynostosis. Chichester, Wiley.
134.
Lattanzi W, Barba M, Di Pietro L, Boyadjiev SA (2017): Genetic advances in craniosynostosis. Am J Med Genet A DOI: 10.1002/ajmg.a. 38159.
135.
Ledda F, Paratcha G, Sandoval-Guzman T, Ibanez CF (2007): GDNF and GFR alpha 1 promote formation of neuronal synapses by ligand- induced cell adhesion. Nat Neurosci 10:293-300.
136.
Leoni V, Caccia C (2015): The impairment of cholesterol metabolism in Huntington disease. Biochim Biophys Acta 1851:1095-1105.
137.
Li N, Bartlett CW (2012): Defining the genetic architecture of human developmental language impairment. Life Sci 90:469-475.
138.
Li X, Black M, Xia S, Zhan C, Bertisch HC, Branch CA, DeLisi LE (2015): Subcortical structure alterations impact language processing in individuals with schizophrenia and those at high genetic risk. Schizophr Res 169:76-82.
139.
Li X, Branch CA, DeLisi LE (2009): Language pathway abnormalities in schizophrenia: a review of fMRI and other imaging studies. Curr Opin Psychiatry 22:131-139.
140.
Li J, Wilkinson B, Clementel VA, Hou J, O'Dell TJ, Coba MP (2016): Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome. Sci Signal 9:rs8.
141.
Liang J, Von den Hoff J, Lange J, Ren Y, Bian Z, Carels CE (2016): MSX1 mutations and associated disease phenotypes: genotype-phenotype relations. Eur J Hum Genet 24:1663-1670.
142.
Liberg B, Rahm C, Panayiotou A, Pantelis C (2016): Brain change trajectories that differentiate the major psychoses. Eur J Clin Invest 46:658-674.
143.
Lin Y, Ma X, Deng W, Han Y, Li M, Liu X, Loh el-W, Li T (2012): Minor physical anomalies in patients with schizophrenia in a Chinese population. Psychiatry Res 200:223-227.
144.
Link AS, Kurinna S, Havlicek S, Lehnert S, Reichel M, Kornhuber J, Winner B, Huth T, Zheng F, Werner S, Alzheimer C (2016): Kdm6b and Pmepa1 as targets of bioelectrically and behaviorally induced activin A signaling. Mol Neurobiol 53:4210-4225.
145.
Liu Y, Harding M, Pittman A, Dore J, Striessnig J, Rajadhyaksha A, Chen X (2014): Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. J Neurophysiol 112:1119-1130.
146.
Liu JA, Wu MH, Yan CH, Chau BK, So H (2013): Phosphorylation of Sox9 is required for neural crest delamination and is regulated downstream of BMP and canonical Wnt signalling. Proc Natl Acad Sci USA 110:2882-2887.
147.
Lopez LM, Harris SE, Luciano M, Liewald D, Davies G, Gow AJ, Tenesa A, Payton A, Ke X, Whalley LJ, Fox H, Haggerty P, Ollier W, Pickles A, Porteous DJ, Horan MA, Pendleton N, Starr JM, Deary IJ (2012): Evolutionary conserved longevity genes and human cognitive abilities in elderly cohorts. Eur J Hum Genet 20:341-347.
148.
Lorenzo J, Barton B, Arnold SS, North KN (2013): Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study. J Pediatr 163:1479-1483.e1.
149.
Lorenzo J, Barton B, Arnold SS, North KN (2015): Developmental trajectories of young children with neurofibromatosis type 1: a longitudinal study from 21 to 40 months of age. J Pediatr 166:1006-1012.e1.
150.
Lupyan G, Dale R (2010): Language structure is partly determined by social structure. PLoS One 5:e8559.
151.
Lyons GE, Micales BK, Herr MJ, Horrigan SK, Namciu S, Shardy D, Stavnezer E (1994): Protooncogene c-ski is expressed in both proliferating and postmitotic neuronal populations. Dev Dyn 201:354-365.
152.
Mariani LL, Tesson C, Charles P, Cazeneuve C, Hahn V, Youssov K, Freeman L, Grabli D, Roze E, Noël S, Peuvion JN, Bachoud-Levi AC, Brice A, Stevanin G, Durr A (2016): Expanding the spectrum of genes involved in Huntington disease using a combined clinical and genetic approach. JAMA Neurol 73:1105-1114.
153.
Mariën P, Ackermann H, Adamaszek M, Barwood CH, Beaton A, Desmond J, De Witte E, Fawcett AJ, Hertrich I, Küper M, Leggio M, Marvel C, Molinari M, Murdoch BE, Nicolson RI, Schmahmann JD, Stoodley CJ, Thürling M, Timmann D, Wouters E, Ziegler W (2014): Consensus paper: language and the cerebellum: an ongoing enigma. Cerebellum 13:386-410.
154.
Marschallinger J, Sah A, Schmuckermair C, Unger M, Rotheneichner P, Kharitonova M, Waclawiczek A, Gerner P, Jaksch-Bogensperger H, Berger S, Striessnig J, Singewald N, Couillard-Despres S, Aigner L (2015): The L-type calcium channel Cav1.3 is required for proper hippocampal neurogenesis and cognitive functions. Cell Calcium 58:606-616.
155.
Martinez-Garay I, Gil-Sanz C, Franco SJ, Espinosa A, Molnár Z, Mueller U (2016): Cadherin 2/4 signaling via PTP1B and catenins is crucial for nucleokinesis during radial neuronal migration in the neocortex. Development 143:2121-2134.
156.
Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E (2009): Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9:17.
157.
Mascheretti S, Riva V, Giorda R, Beri S, Lanzoni LF, Cellino MR, Marino C (2014): KIAA0319 and ROBO1: evidence on association with reading and pleiotropic effects on language and mathematics abilities in developmental dyslexia. J Hum Genet 59:189-197.
158.
Mauney SA, Pietersen CY, Sonntag KC, Woo TU (2015): Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia. Schizophr Res 169:374-380.
159.
McDonald-McGinn DM, Feret H, Nah HD, Bartlett SP, Whitaker LA, Zackai EH (2010): Metopic craniosynostosis due to mutations in GLI3: a novel association. Am J Med Genet A 152A:1654-1660.
160.
McGrath J, El-Saadi O, Grim V, Cardy S, Chapple B, Chant D, Lieberman D, Mowry B (2002): Minor physical anomalies and quantitative measures of the head and face in patients with psychosis. Arch Gen Psychiatry 59:458-464.
161.
McLarren KW, Litsiou A, Streit A (2003): DLX5 positions the neural crest and preplacode region at the border of the neural plate. Dev Biol 259:34-47.
162.
Michelato A, Bonvicini C, Ventriglia M, Scassellati C, Randazzo R, Bignotti S, Beneduce R, Riva MA, Gennarelli M (2004): 3′UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci Lett 357:235-237.
163.
Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M, Hosseini SM, Tajdini M, Ghaleiha A, Akhondzadeh S (2013): Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study. CNS Drugs 27:57-65.
164.
Mølsted K, Boers M, Kjaer I (2010): The morphology of the sella turcica in velocardiofacial syndrome suggests involvement of a neural crest developmental field. Am J Med Genet A 152A:1450-1457.
165.
Montano C, Taub MA, Jaffe A, Briem E, Feinberg JI, Trygvadottir R, Idrizi A, Runarsson A, Berndsen B, Gur RC, Moore TM, Perry RT, Fugman D, Sabunciyan S, Yolken RH, Hyde TM, Kleinman JE, Sobell JL, Pato CN, Pato MT, Go RC, Nimgaonkar V, Weinberger DR, Braff D, Gur RE, Fallin MD, Feinberg AP (2016): Association of DNA methylation differences with schizophrenia in an epigenome-wide association study. JAMA Psychiatry 73:506-514.
166.
Moore L, Kyaw M, Vercammen A, Lenroot R, Kulkarni J, Curtis J, O'Donnell M, Carr VJ, Shannon Weickert C, Weickert TW (2013): Serum testosterone levels are related to cognitive function in men with schizophrenia. Psychoneuroendocrinology 38:1717-1728.
167.
Moran P, Stokes J, Marr J, Bock G, Desbonnet L, Waddington J, O'Tuathaigh C (2016): Gene × environment interactions in schizophrenia: evidence from genetic mouse models. Neural Plast 2016:2173748.
168.
Murphy E (2015): The brain dynamics of linguistic computation. Front Psychol 6:1515.
169.
Murphy E, Benítez-Burraco A (2016a): Bridging the gap between genes and language deficits in schizophrenia: an oscillopathic approach. Front Hum Neurosci 10:422.
170.
Murphy E, Benítez-Burraco A (2016b): Language deficits in schizophrenia and autism as related oscillatory connectomopathies: an evolutionary account. Neurosci Biobehav Rev S0149-763430155-5.
171.
Nikitczuk JS, Patil SB, Matikainen-Ankney BA, Scarpa J, Shapiro ML, Benson DL, Huntley GW (2014): N-cadherin regulates molecular organization of excitatory and inhibitory synaptic circuits in adult hippocampus in vivo. Hippocampus 24:943-962.
172.
Noroozian M (2014): The role of the cerebellum in cognition: beyond coordination in the central nervous system. Neurol Clin 32:1081-1104.
173.
Ono K, Takebayashi H, Ikeda K, Furusho M, Nishizawa T, Watanabe K, Ikenaka K (2008): Regional- and temporal-dependent changes in the differentiation of Olig2 progenitors in the forebrain, and the impact on astrocyte development in the dorsal pallium. Dev Biol 320:456-468.
174.
Okada N, Fukunaga M, Yamashita F, Koshiyama D, Yamamori H, Ohi K, Yasuda Y, Fujimoto M, Watanabe Y, Yahata N, Nemoto K, Hibar DP, van Erp TG, Fujino H, Isobe M, Isomura S, Natsubori T, Narita H, Hashimoto N, Miyata J, Koike S, Takahashi T, Yamasue H, Matsuo K, Onitsuka T, Iidaka T, Kawasaki Y, Yoshimura R, Watanabe Y, Suzuki M, Turner JA, Takeda M, Thompson PM, Ozaki N, Kasai K, Hashimoto R (2016): Abnormal asymmetries in subcortical brain volume in schizophrenia. Mol Psychiatry 21:1460-1466.
175.
Oliva JL, Rault JL, Appleton B, Lill A (2015): Oxytocin enhances the appropriate use of human social cues by the domestic dog (Canis familiaris) in an object choice task. Anim Cogn 18:767-775.
176.
Owen MJ, Sawa A, Mortensen PB (2016): Schizophrenia. Lancet 388:86-97.
177.
Palaniyappan L, Mallikarjun P, Joseph V, White TP, Liddle PF (2011): Regional contraction of brain surface area involves three large-scale networks in schizophrenia. Schizophr Res 129:163-168.
178.
Palomino A, Vallejo-Illarramendi A, González-Pinto A, Aldama A, González-Gómez C, Mosquera F, González-García G, Matute C (2006): Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr Res 86:321-322.
179.
Parisi L, Di Filippo T, Roccella M (2015): Behavioral phenotype and autism spectrum disorders in Cornelia de Lange syndrome. Ment Illn 7:5988.
180.
Park DH, Hong SJ, Salinas RD, Liu SJ, Sun SW, Sgualdino J, Testa G, Matzuk MM, Iwamori N, Lim DA (2014): Activation of neuronal gene expression by the JMJD3 demethylase is required for postnatal and adult brain neurogenesis. Cell Rep 8:1290-1299.
181.
Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, Sparks C, Choi CH, Oghalai J, Curran S, Murphy KC, Monks S, Williams N, O'Donovan MC, Owen MJ, Scambler PJ, Lindsay E (2006): Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103:7729-7734.
182.
Payne JM, Porter M, Pride NA, North KN (2016): Theory of mind in children with neurofibromatosis type 1. Neuropsychology 30:439-448.
183.
Pearlson GD, Folley BS (2008): Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework. Schizophr Bull 34:722-733.
184.
Peter B, Wijsman EM, Nato AQ Jr; University of Washington Center for Mendelian Genomics, Matsushita MM, Chapman KL, Stanaway IB, Wolff J, Oda K, Gabo VB, Raskind WH (2016): Genetic candidate variants in two multigenerational families with childhood apraxia of speech. PLoS One 11:e0153864.
185.
Petrella LI, Cai Y, Sereno JV, Gonçalves SI, Silva AJ, Castelo-Branco M (2016): Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition. Genes Brain Behav 15:637-646.
186.
Pinggera A, Lieb A, Benedetti B, Lampert M, Monteleone S, Liedl KR, Tuluc P, Striessnig J (2015): CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biol Psychiatry 77:816-822.
187.
Potkin SG, Macciardi F, Guffanti G, Fallon JH, Wang Q, Turner JA, Lakatos A, Miles MF, Lander A, Vawter MP, Xie X (2010): Identifying gene regulatory networks in schizophrenia. Neuroimage 53:839-847.
188.
Potkin SG, Turner JA, Guffanti G, Lakatos A, Fallon JH, Nguyen DD, Mathalon D, Ford J, Lauriello J, Macciardi F; FBIRN (2009): A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull 35:96-108.
189.
Praharaj SK, Sarkar S, Sinha VK (2012): External ear abnormalities in existing scales for minor physical anomalies: are they enough? Psychiatry Res 198:324-326.
190.
Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'Dushlaine C, Chambert K, Bergen SE, Kähler A, Duncan L, Stahl E, Genovese G, Fernández E, Collins MO, Komiyama NH, Choudhary JS, Magnusson PK, Banks E, Shakir K, Garimella K, Fennell T, DePristo M, Grant SG, Haggarty SJ, Gabriel S, Scolnick EM, Lander ES, Hultman CM, Sullivan PF, McCarroll SA, Sklar P (2014): A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506:185-190.
191.
Rajchgot H, Fathalli F, Rajchgot P, Menezes N, Joober R, Boksa P (2009): Decreased tooth size in schizophrenia. Schizophr Res 110:194-196.
192.
Ramanathan S, Miewald J, Montrose D, Keshavan MS (2015): Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms? Schizophr Res 164:35-39.
193.
Ramsey JM, Schwarz E, Guest PC, van Beveren NJ, Leweke FM, Rothermundt M, Bogerts B, Steiner J, Bahn S (2013): Distinct molecular phenotypes in male and female schizophrenia patients. PLoS One 8:e78729.
194.
Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, Akalin A, Schmeier S, Kanamori-Katayama M, Bertin N, Carninci P, Daub CO, Forrest AR, Gough J, Grimmond S, Han JH, Hashimoto T, Hide W, Hofmann O, Kamburov A, Kaur M, Kawaji H, Kubosaki A, Lassmann T, van Nimwegen E, MacPherson CR, Ogawa C, Radovanovic A, Schwartz A, Teasdale RD, Tegnér J, Lenhard B, Teichmann SA, Arakawa T, Ninomiya N, Murakami K, Tagami M, Fukuda S, Imamura K, Kai C, Ishihara R, Kitazume Y, Kawai J, Hume DA, Ideker T, Hayashizaki Y(2010): An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140:744-752.
195.
Rehkämper G, Frahm HD, Cnotka J (2008): Mosaic evolution and adaptive brain component alteration under domestication seen on the background of evolutionary theory. Brain Behav Evol 71:115-126.
196.
Rich AM, Cho YT, Tang Y, Savic A, Krystal JH, Wang F, Xu K, Anticevic A (2016): Amygdala volume is reduced in early course schizophrenia. Psychiatry Res 250:50-60.
197.
Richter R, Rorbach J, Pajak A, Smith PM, Wessels HJ, Huynen MA, Smeitink JA, Lightowlers RN, Chrzanowska-Lightowlers ZM (2010): A functional peptidyl-tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome. EMBO J 29:1116-1125.
198.
Ripke S, O'Dushlaine C, Chambert K, et al (2013): Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45:1150-1159.
199.
Romano A, Tempesta B, Micioni Di Bonaventura MV, Gaetani S (2016): From autism to eating disorders and more: the role of oxytocin in neuropsychiatric disorders. Front Neurosci 9:497.
200.
Romero T, Nagasawa M, Mogi K, Hasegawa T, Kikusui T (2015): Intranasal administration of oxytocin promotes social play in domestic dogs. Commun Integr Biol 8:e1017157.
201.
Rosa JC, César MC (2016): Role of hexokinase and VDAC in neurological disorders. Curr Mol Pharmacol 9:320-331.
202.
Ruest LB, Hammer RE, Yanagisawa M, Clouthier DE (2003): Dlx5/6‐enhancer directed expression of Cre recombinase in the pharyngeal arches and brain. Genesis 37:188-194.
203.
Ruzicka WB, Subburaju S, Benes FM (2015): Circuit- and diagnosis-specific DNA methylation changes at γ-aminobutyric acid-related genes in postmortem human hippocampus in schizophrenia and bipolar disorder. JAMA Psychiatry 72:541-551.
204.
Sajan SA, Rubenstein JL, Warchol ME, Lovett M (2011): Identification of direct downstream targets of Dlx5 during early inner ear development. Hum Mol Genet 20:1262-1273.
205.
Sakane F, Miyamoto Y (2013): N-cadherin regulates the proliferation and differentiation of ventral midbrain dopaminergic progenitors. Dev Neurobiol 73:518-529.
206.
Salmela E, Renvall H, Kujala J, Hakosalo O, Illman M, Vihla M, Leinonen E, Salmelin R, Kere J (2016): Evidence for genetic regulation of the human parieto-occipital 10-Hz rhythmic activity. Eur J Neurosci 44:1963-1971.
207.
Sánchez-Villagra MR, Geiger M, Schneider RA (2016): The taming of the neural crest: a developmental perspective on the origins of morphological covariation in domesticated mammals. R Soc Open Sci 3:160107.
208.
Sans-Sansa B, McKenna PJ, Canales-Rodríguez EJ, Ortiz-Gil J, López-Araquistain L, Sarró S, Dueñas RM, Blanch J, Salvador R, Pomarol-Clotet E (2013): Association of formal thought disorder in schizophrenia with structural brain abnormalities in language-related cortical regions. Schizophr Res 146:308-313.
209.
Sasai N, Kutejova E, Briscoe J (2014): Integration of signals along orthogonal axes of the vertebrate neural tube controls progenitor competence and increases cell diversity. PLoS Biol 12:e1001907.
210.
Sasayama D, Hattori K, Teraishi T, Hori H, Ota M, Yoshida S, Arima K, Higuchi T, Amano N, Kunugi H (2012): Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia. Schizophr Res 139:201-206.
211.
Saugstad LF (1989a): Mental illness and cognition in relation to age at puberty: a hypothesis. Clin Genet 36:156-167.
212.
Saugstad LF (1989b): Age at puberty and mental illness: towards a neurodevelopmental aetiology of Kraepelin's endogenous psychoses. Br J Psychiatry 155:536-544.
213.
Schneider SA, Marshall KE, Xiao J, LeDoux MS (2012): JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family. Neurogenetics 13:133-140.
214.
Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, Silveira I, Ross CA, Margolis RL, Rudnicki DD (2012): Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis. Ann Neurol 71:245-257.
215.
Shao L, Vawter MP (2008): Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 64:89-97.
216.
Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS (2015): The mitochondrial voltage-dependent anion channel 1 in tumor cells. Biochim Biophys Acta 1848:2547-2575.
217.
Sims R, Hollingworth P, Moskvina V, Dowzell K, O'Donovan MC, Powell J, Lovestone S, Brayne C, Rubinsztein D, Owen MJ, Williams J, Abraham R (2009): Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease. Neurosci Lett 461:54-59.
218.
Sisek-Šprem M, Križaj A, Jukić V, Milošević M, Petrović Z, Herceg M (2015): Testosterone levels and clinical features of schizophrenia with emphasis on negative symptoms and aggression. Nord J Psychiatry 69:102-109.
219.
Srinivasan S, Bettella F, Hassani S, Wang Y, Witoelar A, Schork AJ, Thompson WK, Collier DA, Desikan RS, Melle I, Dale AM, Djurovic S, Andreassen OA (2017): Probing the association between early evolutionary markers and schizophrenia. PLoS One 12:e0169227.
220.
Srinivasan S, Bettella F, Mattingsdal M, Wang Y, Witoelar A, Schork AJ, Thompson WK, Zuber V; Schizophrenia Working Group of the Psychiatric Genomics Consortium, The International Headache Genetics Consortium, Winsvold BS, Zwart JA, Collier DA, Desikan RS, Melle I, Werge T, Dale AM, Djurovic S, Andreassen OA (2016): Genetic markers of human evolution are enriched in schizophrenia. Biol Psychiatry 80:284-292.
221.
St Pourcain B, Cents RA, Whitehouse AJ, Haworth CM, Davis OS, O'Reilly PF, Roulstone S, Wren Y, Ang QW, Velders FP, Evans DM, Kemp JP, Warrington NM, Miller L, Timpson NJ, Ring SM, Verhulst FC, Hofman A, Rivadeneira F, Meaburn EL, Price TS, Dale PS, Pillas D, Yliherva A, Rodriguez A, Golding J, Jaddoe VW, Jarvelin MR, Plomin R, Pennell CE, Tiemeier H, Davey Smith G (2014): Common variation near ROBO2 is associated with expressive vocabulary in infancy. Nat Commun 5:4831.
222.
Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA (2006): Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188:510-518.
223.
Stein CM, Schick JH, Gerry Taylor H, Shriberg LD, Millard C, Kundtz-Kluge A, Russo K, Minich N, Hansen A, Freebairn LA, Elston RC, Lewis BA, Iyengar SK (2004): Pleiotropic effects of a chromosome 3 locus on speech-sound disorder and reading. Am J Hum Genet 74:283-297.
224.
Stephane M, Kuskowski M, Gundel J (2014): Abnormal dynamics of language in schizophrenia. Psychiatry Res 216:320-324.
225.
Stephane M, Pellizzer G, Fletcher CR, McClannahan K (2007): Empirical evaluation of language disorder in schizophrenia. J Psychiatry Neurosci 32:250-258.
226.
Strauss GP, Keller WR, Koenig JI, Gold JM, Frost KH, Buchanan RW (2015): Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia. Schizophr Res 62:47-51.
227.
Sugranyes G, Solé-Padullés C, de la Serna E, Borras R, Romero S, Sanchez-Gistau V, Garcia-Rizo C, Goikolea JM, Bargallo N, Moreno D, Baeza I, Castro-Fornieles J (2017): Cortical morphology characteristics of young offspring of patients with schizophrenia or bipolar disorder. J Am Acad Child Adolesc Psychiatry 56:79-88.
228.
Sun J, Tang Y, Lim KO, Wang J, Tong S, Li H, He B (2014): Abnormal dynamics of EEG oscillations in schizophrenia patients on multiple time scales. IEEE Trans Biomed Eng 61:1756-1764.
229.
Swillen A, Devriendt K, Legius E, Eyskens B, Dumoulin M, Gewillig M (1997): Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with 22q11.2 deletion syndrome. J Med Genet 34:453-458.
230.
Swillen A, Devriendt K, Legius E, Prinzie P, Vogels A, Ghesquiere P, Fryns JP (1999): The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns 10:79-88.
231.
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ , von Mering C (2015): STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43:D447-D452.
232.
Tabler JM, Rice CP, Liu KJ, Wallingford JB (2016): A novel ciliopathic skull defect arising from excess neural crest. Dev Biol 417:4-10.
233.
Takahashi T, Okabe S, Broin PÓ, Nishi A, Ye K, Beckert MV, Izumi T, Machida A, Kang G, Abe S, Pena JL, Golden A, Kikusui T, Hiroi N (2016): Structure and function of neonatal social communication in a genetic mouse model of autism. Mol Psychiatry 21:1208-1214.
234.
Takahasi M, Okanoya K (2010): Song learning in wild and domesticated strains of white-rumped munia, Lonchura striata, compared by cross-fostering procedures: domestication increases song variability by decreasing strain-specific bias. Ethology 116:396-405.
235.
Tanimoto Y, Veistinen L, Alakurtti K, Takatalo M, Rice DP (2012): Prevention of premature fusion of calvarial suture in GLI-Kruppel family member 3 (Gli3)-deficient mice by removing one allele of Runt-related transcription factor 2 (Runx2). J Biol Chem 287:21429-438.
236.
Teffer K, Semendeferi K (2012): Human prefrontal cortex: evolution, development, and pathology. Prog Brain Res 195:191-218.
237.
Theofanopoulou C (2016): Implications of oxytocin in human linguistic cognition: from genome to phenome. Front Neurosci 10:271.
238.
Thomas J (2014): Self-Domestication and Language Evolution; PhD thesis, University of Edinburgh, Edinburgh.
239.
Trixler M, Tényi T, Csábi G, Szabó R (2001): Minor physical anomalies in schizophrenia and bipolar affective disorder. Schizophr Res 52:195-201.
240.
Tunca Z, Kıvırcık Akdede B, Özerdem A, Alkın T, Polat S, Ceylan D, Bayın M, Cengizçetin Kocuk N, Şimşek S, Resmi H, Akan P (2015): Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders. Eur Psychiatry 30:198-204.
241.
Van Lierde KM, Mortier G, Loeys B, Baudonck N, De Ley S, Marks LA, Van Borsel J (2007): Overall intelligibility, language, articulation, voice and resonance characteristics in a child with Shprintzen-Goldberg syndrome. Int J Pediatr Otorhinolaryngol 71:721-728.
242.
van Os J, Kapur S (2009): Schizophrenia. Lancet 374:635-645.
243.
van Reeuwijk J, Maugenre S, van den Elzen C, Verrips A, Bertini E, Muntoni F, Merlini L, Scheffer H, Brunner HG, Guicheney P, van Bokhoven H (2006): The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation. Hum Mutat 27:453-459.
244.
Veistinen L, Takatalo M, Tanimoto Y, Kesper DA, Vortkamp A, Rice DP (2012): Loss-of-function of Gli3 in mice causes abnormal frontal bone morphology and premature synostosis of the interfrontal suture. Front Physiol 3:121.
245.
Vercammen A, Skilleter AJ, Lenroot R, Catts SV, Weickert CS, Weickert TW (2013): Testosterone is inversely related to brain activity during emotional inhibition in schizophrenia. PLoS One 8:e77496.
246.
Vincentz JW, Casasnovas JJ, Barnes RM, Que J, Clouthier DE, Wang J, Firulli AB (2016): Exclusion of Dlx5/6 expression from the distal-most mandibular arches enables BMP-mediated specification of the distal cap. Proc Natl Acad Sci USA 113:7563-7568.
247.
von Tetzchner S, Fosse P, Elmerskog B (2013): Juvenile neuronal ceroid lipofuscinosis and education. Biochim Biophys Acta 1832:1894-1905.
248.
Walker E, Mittal V, Tessner K (2008): Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 4:189-216.
249.
Walker EF, Walder DJ, Reynolds F (2001): Developmental changes in cortisol secretion in normal and at-risk youth. Dev Psychopathol 13:721-732.
250.
Wang R, Chen CC, Hara E, Rivas MV, Roulhac PL, Howard JT, Chakraborty M, Audet JN, Jarvis ED (2015): Convergent differential regulation of SLIT-ROBO axon guidance genes in the brains of vocal learners. J Comp Neurol 523:892-906.
251.
Wegman J, Tyborowska A, Hoogman M, Arias Vásquez A, Janzen G (2016): The brain- derived neurotrophic factor Val66Met polymorphism affects encoding of object locations during active navigation. Eur J Neurosci DOI: 10.1111/ejn.13416.
252.
Wilkins, AS, Wrangham RW, Fitch WT (2014): The “domestication syndrome” in mammals: a unified explanation based on neural crest cell behavior and genetics. Genetics 197:795-808.
253.
Wilson SL, Wilson JP, Wang C, Wang B, McConnell SK (2012): Primary cilia and Gli3 activity regulate cerebral cortical size. Dev Neurobiol 72:1196-1212.
254.
Wray A, Grace GW (2007): The consequences of talking to strangers: evolutionary corollaries of socio-cultural influences on linguistic form. Lingua 117:543-578.
255.
Xu T, Stephane M, Parhi KK (2012): Selection of abnormal neural oscillation patterns associated with sentence-level language disorder in schizophrenia. Conf Proc IEEE Eng Med Biol Soc 2012:4923-4926.
256.
Xu T, Stephane M, Parhi KK (2013): Multidimensional analysis of the abnormal neural oscillations associated with lexical processing in schizophrenia. Clin EEG Neurosci 44:135-143.
257.
Yamauchi K, Varadarajan SG, Li JE, Butler SJ (2013): Type Ib BMP receptors mediate the rate of commissural axon extension through inhibition of cofilin activity. Development 140:333-342.
258.
Yang H, Manya H, Kobayashi K, Jiao H, Fu X, Xiao J, Li X, Wang J, Jiang Y, Toda T, Endo T, Wu X, Xiong H (2016): Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation. J Hum Genet 61:753-759.
259.
Yoshitsugu K, Yamada K, Toyota T, Aoki-Suzuki M, Minabe Y, Nakamura K, Sekine Y, Suzuki K, Takei N, Itokawa M, Mori N, Yoshikawa T (2006): A novel scale including strabismus and “cuspidal ear” for distinguishing schizophrenia patients from controls using minor physical anomalies. Psychiatry Res 145:249-258.
260.
Yuan A, Li W, Yu T, Zhang C, Wang D, Liu D, Xu Y, Li H, Yu S (2013): SOX10 rs139883 polymorphism is associated with the age of onset in schizophrenia. J Mol Neurosci 50:333-338.
261.
Yüksel RN, Altunsoy N, Tikir B, Cingi Külük M, Unal K, Goka S, Aydemir C, Goka E (2014): Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Ther Adv Psychopharmacol 4:268-275.
262.
Zeidán-Chuliá F, de Oliveira BH, Casanova MF, Casanova EL, Noda M, Salmina AB, Verkhratsky A (2016): Up-regulation of oligodendrocyte lineage markers in the cerebellum of autistic patients: evidence from network analysis of gene expression. Mol Neurobiol 53:4019-4025.
263.
Zhang XY (2016): BDNF polymorphisms are associated with cognitive performance in schizophrenia patients versus healthy controls. J Clin Psychiatry 77:e1011- e1018.
264.
Zhang D, Ighaniyan S, Stathopoulos L, Rollo B, Landman K, Hutson J, Newgreen D (2014): The neural crest: a versatile organ system. Birth Defects Res C Embryo Today 102:275-298.
265.
Zhou H, Hu S, Matveev R, Yu Q, Li J, Khaitovich P, Jin L, Lachmann M, Stoneking M, Fu Q, Tang K (2015): A chronological atlas of natural selection in the human genome during the past half-million years. BioRxiv DOI: .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.